Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00097539
Status:
COMPLETED
Last Update Posted:
2017-02-15
First Post:
2004-11-24
Brief Title:
National Cooperative Growth Study NCGS A Post-marketing Surveillance Program for Nutropin Nutropin AQ Nutropin Depot and Protropin
Sponsor:
Genentech Inc
Organization:
Genentech Inc
Study Overview
Official Title:
Genentech National Cooperative Growth Study NCGS Post-Marketing Surveillance Program For Nutropin AQ Somatropin rDNA Origin Injection Nutropin Somatropin rDNA Origin for Injection and Protropin Somatrem for Injection
Status:
COMPLETED
Status Verified Date:
2016-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this multicenter open-label observational post-marketing surveillance study is to collect long term safety and efficacy information on growth hormone GH products Protropin somatrem for injection Nutropin somatropin for injection Nutropin AQ somatropin for injection and Nutropin Depot somatropin for injectable suspension in the treatment of pediatric growth disorders for which GH is prescribed
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None